Allergy

06 March 2009

Under-tongue therapy for bee-sting

For people who are strongly allergic to bee venom, desensitization using under-the-tongue immunotherapy may be safer than injection immunotherapy, says researchers.

0

For people who are strongly allergic to bee venom, desensitization using sublingual (i.e., under-the-tongue) immunotherapy may be safer than injection immunotherapy, according to a proof-of-concept clinical trial conducted in Italy.

"Our research opens a new possible application of sublingual immunotherapy, which was never proposed for hymenoptera allergy," Dr. Giovanni Passalacqua told Reuters Health.

Risk of severe reactions
The standard way to desensitize patients with bee sting allergy is to administer small, increasing doses of venom by subcutaneous injections.

However, there is a "particular risk of systemic/severe reactions" with this approach, the research team notes in the Journal of Allergy and Clinical Immunology.

On the other hand, they say, "systemic side effects are rare, severe adverse events are exceptional, and the common local side effects are mild and self-limiting" with sublingual immunotherapy, or SLIT.

How the trial was done
To evaluate SLIT's suitability for hymenoptera allergy, Passalacqua, at the University of Genoa, and his associates conducted a trial involving patients who had experienced large local reactions - swellings of 10 centimeters or more lasting more than 24 hours to bee stings.

Venom extract was administered under the tongue daily, starting with a tiny amount and building to bigger doses over 6 months. The trial was completed by 14 patients randomly assigned to SLIT and 12 assigned to placebo.

The maximum diameter of the local reaction when participants were deliberately exposed to a "challenge" sting was significantly reduced only in the active treatment group, the investigators report.

SLIT with honeybee venom was well tolerated, the report indicates, with no adverse events or discomfort reported by the subjects.

"Other studies are currently ongoing to better define the mechanisms of action of SLIT, and to assess its safety when multiple allergens are used in the same patient," Passalacqua noted. (Karla Gale/Reuters Health) SOURCE: Journal of Allergy and Clinical Immunology, July 2008.

Read more:
Stress, anxiety worsen allergies
Peanut allergy cure on its way

August 2008

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Allergy expert

Dr Morris is the Principal Allergist at the Cape Town and Johannesburg Allergy Clinics with postgraduate diplomas in Allergology, Dermatology, Paediatrics and Family Medicine dealing with both adult and childhood allergies. obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules